Phillip Barnette
Pediatric Hematology-Oncology · Salt Lake City, UTNPI 1831278308
Payments from drug & device makers
What this record shows
That places this record below the midpoint for pediatric hematology-oncology clinicians in UT, where the typical reported total is $195.
No general payments reported
No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.
$885,720in research payments, 2019–2025
Across 104 payments — averaging $8516.54 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Jazz Pharmaceuticals Inc.$471K
- Merck$139K
- AbbVie$128K
- Novartis$113K
- Incyte Corporation$30K
- E.r. Squibb & Sons, L.L.C.$5K
- plus $813 from 1 others
How this compares
$0 in reported general payments places this provider in the 10th percentile of 24 pediatric hematology-oncology providers in Utah.
Other pediatric hematology-oncology in Salt Lake City
- Richard LemonsSalt Lake City$753K
- Luke MaeseSalt Lake City$332K
- Hassan YaishSalt Lake City$113K
- Julie AschSalt Lake City$62K
- Ahmad RayesSalt Lake City$5K
- Nicholas WhippleSalt Lake City$3K
- Michell Lozano ChingaSalt Lake City$1K
- Soohee ChoSalt Lake City$948
- Joseph DolanSalt Lake City$295
- Mark FluchelSalt Lake City$235
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.